Clinical Trials Logo

Pars Plana Vitrectomy clinical trials

View clinical trials related to Pars Plana Vitrectomy.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05592912 Not yet recruiting - Clinical trials for Pars Plana Vitrectomy

Safety and Efficacy of HydroLenz for Vitrectomy-Induced Lens Opacities

Start date: January 1, 2024
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to provide safety data for two different dosages of HydroLenz. Secondary objectives are to provide preliminary data to determine whether HydroLenz has the same effect in humans as it does in the porcine model; to confirm the reliability of methods for evaluating lens opacity; and, to acquire information that can be used to design the pivotal study.